{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T08:36:21Z","timestamp":1697186181016},"reference-count":0,"publisher":"Oxford University Press (OUP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1997,6,1]]},"DOI":"10.1093\/jjco\/27.3.146","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T18:55:22Z","timestamp":1027709722000},"page":"146-153","source":"Crossref","is-referenced-by-count":13,"title":["Phase I study of cladribine (2-chlorodeoxyadenosine) in lymphoid malignancies. Cladribine Study Group"],"prefix":"10.1093","volume":"27","author":[{"given":"K","family":"Tobinai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","container-title":["Japanese Journal of Clinical Oncology"],"original-title":[],"link":[{"URL":"http:\/\/academic.oup.com\/jjco\/article-pdf\/27\/3\/146\/5221867\/27-3-146.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,23]],"date-time":"2017-08-23T12:41:41Z","timestamp":1503492101000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jjco\/article-lookup\/doi\/10.1093\/jjco\/27.3.146"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,6,1]]},"references-count":0,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.1093\/jjco\/27.3.146","relation":{},"ISSN":["1465-3621"],"issn-type":[{"value":"1465-3621","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,6,1]]}}}